Vertex Pharmaceuticals Incorporated company logo
Vertex Pharmaceuticals Incorporated logo

VRTX Cash & Equivalents

Annual Cash & Cash Equivalents

$6.61B$492.60M+8.05%

Summary

Current Value
As of today, VRTX annual cash & cash equivalents is $6.61B, up +8.05% on
Historical Performance
VRTX annual cash & cash equivalents is down -38.71% over the past 3 years, down -0.73% over the past 5 years
All-Time High Comparison
VRTX annual cash & cash equivalents is currently -41.09% below its historical high of $11.22B set on
3-Year Low Comparison
VRTX annual cash & cash equivalents is +8.05% above its 3-year low of $6.12B reached on
Sector Comparison
VRTX annual cash & cash equivalents is higher than 98.32% of companies in Healthcare sector

Cash and Cash Equivalents Chart

SUGGESTED SERIES

Performance

VRTX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash & Cash Equivalents$6.61B+8.1%-38.7%-0.7%+541.0%
Quarterly Cash & Cash Equivalents$6.31B+0.3%-47.1%-9.4%+790.0%
Price$537.79+23.9%+53.4%+185.7%+1753.8%
Annual Current Assets$11.20B+16.7%-15.4%+37.7%+959.7%
Annual Total Liabilities$7.48B+11.9%+76.4%+143.9%+512.1%
Annual Working Capital$7.34B+21.7%-30.1%+17.3%+1160.6%
Annual Net Income$3.95B+838.1%+19.0%+45.8%+623.9%

Cash and Cash Equivalents Highs

VRTX Annual Cash & Cash Equivalents Highs Comparison
PeriodHighDateCurrent
3Y$11.22B-41.1%
5Y$11.22B-41.1%
All$11.22B-41.1%

Cash and Cash Equivalents Lows

VRTX Annual Cash & Cash Equivalents Lows Comparison
PeriodLowDateCurrent
3Y$6.12B+8.1%
5Y$6.12B+8.1%
All$4.40M>+9999.0%

Cash and Cash Equivalents History

YearValueChange
$6.61B+8.1%
$6.12B-45.5%
$11.22B+4.0%
$10.79B+43.2%
$7.53B+13.1%
$6.66B+74.5%
$3.82B+20.5%
$3.17B+51.6%
$2.09B+39.6%
$1.50B+32.9%
$1.13B-19.4%
$1.40B-4.6%
$1.47B+5.3%
$1.39B+36.3%
$1.02B-1.0%
$1.03B-19.7%
$1.28B+54.4%
$832.10M+80.5%
YearValueChange
$460.87M-34.6%
$704.63M+95.1%
$361.16M-7.9%
$392.32M-32.7%
$583.16M-8.2%
$634.98M-14.6%
$743.20M+91.3%
$388.60M+106.9%
$187.80M-23.5%
$245.65M-12.2%
$279.67M+114.5%
$130.36M+49.9%
$86.98M-18.3%
$106.47M+104.3%
$52.10M+19.2%
$43.70M-15.1%
$51.49M+1,070.2%
$4.40M-

FAQ

What is the current annual cash & cash equivalents of VRTX?
As of today, VRTX annual cash & cash equivalents is $6.61B
What is 1-year change in VRTX annual cash & cash equivalents?
VRTX annual cash & cash equivalents is up +8.05% year-over-year
What is 3-year change in VRTX annual cash & cash equivalents?
VRTX annual cash & cash equivalents is down -38.71% over the past 3 years
How far is VRTX annual cash & cash equivalents from its all-time high?
VRTX annual cash & cash equivalents is currently -41.09% below its historical high of $11.22B set on December 31, 2023
How does VRTX annual cash & cash equivalents rank versus sector peers?
VRTX annual cash & cash equivalents is higher than 98.32% of companies in Healthcare sector
When is VRTX next annual earnings release?
The next annual earnings release for VRTX is on

Cash and Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

Data Sources & References

  1. VRTX Official Website www.vrtx.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875320/000087532026000056/0000875320-26-000056-index.htm
  3. VRTX Profile on Yahoo Finance finance.yahoo.com/quote/VRTX
  4. VRTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrtx